Deferred Tax Assets, Valuation Allowance of CUMBERLAND PHARMACEUTICALS INC from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
CUMBERLAND PHARMACEUTICALS INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • CUMBERLAND PHARMACEUTICALS INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $22,080,000, a 0.59% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

CUMBERLAND PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $22,080,000 +$130,000 +0.59% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q4 2024 $21,950,000 +$80,672 +0.37% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q4 2023 $21,869,328 +$311,544 +1.4% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q4 2022 $21,557,784 +$1,795,862 +9.1% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q4 2021 $19,761,922 +$565,801 +2.9% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q4 2020 $19,196,121 +$684,960 +3.7% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q4 2019 $18,511,161 +$1,129,109 +6.5% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q4 2018 $17,382,052 +$1,749,817 +11% 31 Dec 2018 8-K 10 Dec 2020
Q1 2018 $15,900,000 $0 0% 31 Mar 2018 10-K 12 Mar 2019 2018 FY
Q4 2017 $15,632,235 +$15,243,735 +3924% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q3 2017 $15,900,000 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 $15,900,000 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $15,900,000 31 Mar 2017 10-K 09 Mar 2018 2017 FY
Q4 2016 $388,500 +$203,003 +109% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q4 2015 $185,497 +$33,423 +22% 31 Dec 2015 10-K 13 Mar 2017 2016 FY
Q4 2014 $152,074 +$20,457 +16% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q4 2013 $131,617 +$23,299 +22% 31 Dec 2013 10-K 09 Mar 2015 2014 FY
Q4 2012 $108,318 +$13,859 +15% 31 Dec 2012 10-K 11 Mar 2014 2013 FY
Q4 2011 $94,459 31 Dec 2011 10-K 12 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.